Studies show safety, efficacy of RSV preventive drug in kids - CIDRAP
Two studies in *Pediatrics* show nirsevimab's safety and efficacy in preventing RSV in infants and children, with Spain's universal RSV prevention via nirsevimab reducing hospitalizations by 63%. Additionally, Oregon research finds a strong correlation between viral wastewater concentration and community respiratory tests for flu, RSV, and COVID-19.
Reference News
Studies show safety, efficacy of RSV preventive drug in kids - CIDRAP
Two studies in *Pediatrics* show nirsevimab's safety and efficacy in preventing RSV in infants and children, with Spain's universal RSV prevention via nirsevimab reducing hospitalizations by 63%. Additionally, Oregon research finds a strong correlation between viral wastewater concentration and community respiratory tests for flu, RSV, and COVID-19.